| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 731017 | 1201491001 | FINTEPLA 2,2 mg/ml SOLUCION ORAL | FINTEPLA 2,2 mg/ml SOLUCION ORAL, 1 frasco de 120 ml | 2 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201491001/1201491001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201491001/1201491001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 8910 | 21333 | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2023-06-01 | View Edit Delete | ||||||||||||
| 731018 | 1201491001 | FINTEPLA 2,2 mg/ml SOLUCION ORAL | FINTEPLA 2,2 mg/ml SOLUCION ORAL, 1 frasco de 360 ml | 2 mg/ml | 6 | 360 | 26 | 1 frasco de 360 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1201491001/1201491001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201491001/1201491001_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 8910 | 21333 | 2021-06-02 | 1 | 1 | 1 | 2021-06-03 | 2021-06-02 | 1 | 2023-06-01 | View Edit Delete | ||||||||||||
| 759855 | 1211620003 | SAPROPTERINA DIPHARMA 100 MG POLVO PARA SOLUCION ORAL EFG | SAPROPTERINA DIPHARMA 100 MG POLVO PARA SOLUCION ORAL EFG, 30 sobres | 100 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211620003/1211620003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211620003/1211620003_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40888 | 16109 | 2022-12-22 | 1 | 1 | 1 | 2022-12-23 | 2022-12-22 | 1 | 2023-06-15 | View Edit Delete | ||||||||||||
| 759856 | 1211620004 | SAPROPTERINA DIPHARMA 500 MG POLVO PARA SOLUCION ORAL EFG | SAPROPTERINA DIPHARMA 500 MG POLVO PARA SOLUCION ORAL EFG, 30 sobres | 500 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1211620004/1211620004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1211620004/1211620004_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40888 | 16109 | 2022-12-22 | 1 | 1 | 1 | 2022-12-23 | 2022-12-22 | 1 | 2023-07-05 | View Edit Delete | ||||||||||||
| 761619 | 66071 | CLARELUX 500 microgramos/g ESPUMA CUTANEA EN ENVASE A PRESION. | CLARELUX 500 microgramos/g ESPUMA CUTANEA EN ENVASE A PRESION. , 1 envase a presión de 100 g | 0,5 mg/g | 34 | 100 | 21 | 1 envase a presión de 100 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66071/66071_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66071/66071_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2219 | 2219 | 2004-05-28 | 1 | 1 | 1 | 2021-01-14 | 2021-01-14 | 1 | 2021-01-15 | View Edit Delete | ||||||||||||
| 988220 | 58263 | GASTRODENOL 120 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA | GASTRODENOL 120 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA , 50 comprimidos | 180 mg | 5 | 50 | 10 | 50 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58263/58263_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58263/58263_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67885 | 67885 | 1990-07-01 | 1 | 1 | 1 | 1990-07-01 | 1990-07-01 | 1 | 2011-10-26 | View Edit Delete |